Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.



October 8, 2019

October is national Breast Cancer Awareness Month, and the Rush system is holding free events throughout the month to educate women about breast cancer screenings and treatment. 

September 5, 2019

Rush University Medical Center has received a three-year certification from the American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI) by demonstrating that the Cancer Center’s processes surpass national benchmarks for providing high-quality care.  


October 24, 2018

Rush University Medical Center has received a $5 million donation from Chicago philanthropists Robert and Emily King that will accelerate blood cancer immunotherapy research and the development of new treatment options. 

October 15, 2018

Mia Levy, MD, PhD, a breast cancer specialist and nationally recognized precision oncology leader, has been appointed director of the Rush University Cancer Center.  

September 11, 2018

Rush is testing whether a vaccine can help people’s own immune system slow the spread of glioblastomas, a deadly form of brain cancer.

March 13, 2018

The Commission on Cancer has granted the Rush University Cancer Center accreditation through 2020 following an extensive onsite survey that demonstrated how Rush has exceeded 34 quality of care standards and sustained excellence across four domains of care: access and service, satisfaction and well-being, quality of care and cancer outcomes.

March 13, 2018

Dana Hayden, MD, thinks that you’re never too young to be screened for colon cancer — provided you have symptoms of the disease, that is.

March 1, 2018

Surgical oncologist Dr. Cristina O’Donoghue is one of less than 30 surgeons in the country to trained to perform isolated limb infusion, which delivers high doses of chemotherapy to an affected arm or leg but not the rest of the body.

January 2, 2018

Rush University Medical Center has received a $275,000 grant from the National Institutes of Health for research aimed at developing a blood test to detect lung cancer.

October 19, 2017

Certain cancer cells stave off their death with help from a particular molecule in a protein involved in the body’s immune system response, a research team at Rush University Medical Center has found.